StockWatch
·

BHARAT FORGE LTD. Q1 FY27 Results

BHARATFORGQ1 FY27 Results
Filing
Result:Weak· Market: CrashedOne-off hitMargin squeeze

Beat/Miss: Miss · Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValueQ4 FY26Q1 FY26
Revenue4.6K Cr2.5%18.7%
Total Income4.7K Cr2.5%18.7%
Expenditure4.3K Cr4.8%20.9%
PBT55.71 Cr85.8%86.5%
Net Profit-89.89 Cr138.5%131.7%
OPM7.57%7.44pp9.65pp
NPM-1.91%7.01pp9.08pp
EPS1.8861.3%68.3%
View full financials

Adjusted PAT fell ~5.6% YoY/19.3% QoQ with EBITDA margin compressing to ~15-16% from ~17%, a clear miss against street expectations of ~25% PAT growth despite healthy 18.7% revenue growth.

BHARAT FORGE · Q1 FY27 · THE VERDICT

Revenue surge masks profitability collapse; cost recovery will be gradual

Revenue surged 18.7% to ₹4,640 crore, yet consolidated net profit swung to a ₹89.9 crore loss. Restructuring charges, a three-month US press breakdown, and energy cost inflation explain the wipeout—but recovery is gradual, leaving near-term execution risk unresolved.

13 Aug 2026 · 6 min read

The disconnect that defines Q1

Revenue grew 18.7% to ₹4,640 crore and consolidated EBITDA rose 10.3% to ₹752 crore, yet net profit swung to a ₹89.9 crore loss. Management framed Q1 as "reasonable given the operating environment"—a claim contradicted by the bottom line. The gap between top-line momentum and profit collapse is the quarter's real story.

Consolidated revenue

₹4,640 Cr

+18.7% YoY

EBITDA

₹752 Cr

+10.3% YoY

EBITDA margin

16.2%

−160 bps inflation hit

Net profit

−₹89.9 Cr

−131.7% YoY

What hit profitability

Four forces wiped out profit despite strong top-line growth. First, restructuring charges: ₹24 crore in India (manpower redundancy) and EUR 30 million (€30M) in Germany for the Bharat Forge CDP closure. Second, a three-month steel forging press breakdown in the US that halted production entirely, resulting in a ₹4 crore EBITDA loss. Third, energy and logistics cost inflation that compressed consolidated EBITDA margin by 160 basis points (from ~26.2% to 16.2%). Fourth, broader cost absorption across subsidiaries and the European segment (which reported only a 3% margin).

The EUR 30 crore restructuring charge is non-cash now but will flow as ₹330 crore in redundancy payouts over the next 6–12 months. Combined, these one-time items and operational headwinds erased all of Q1's EBITDA upside.

Management's claims vs. what holds up

Validation of key claims against reported results

Q1 was a reasonable quarter given the operating environment

Consolidated net loss ₹89.9 Cr; PAT YoY fell 131.7%

Contradicted

Strong business sentiment in North America

US EBITDA loss ₹4 Cr due to 3-month steel forging press breakdown

Overstated

Normalized EBITDA margin would be ~28% (excluding 160 bps cost impact)

Reported margin 16.2%; cost recovery will be gradual

Supported, but recovery slower than implied

₹1,800 Cr capex with high capital output ratio and good margins

Asset turnover >1.5x expected; no margin % quantified for new capex

Partially supported

What changed on this call

  • India growth guidance narrowed: 'nearly 25%' → '20–25%'

  • Capex doubled: ₹800–850 Cr → ₹1,800 Cr organic India capex

  • Fundraise announced: ₹2,500 Cr for capex + M&A war chest

  • Defense order book hit record ₹11,196 Cr with marine turbine breakthrough

  • Consolidated PAT collapsed: prior profit → −₹89.9 Cr loss

  • EBITDA margin compressed 160 bps due to cost inflation; recovery guidance 'gradual'

The bull-bear ledger

What the bull case owns
  • Defense order book ₹11,196 Cr multi-year visibility; largest naval order to date

  • India revenue 18.7% YoY, on track for 20–25% FY27 guidance

  • Aerospace base ₹400 Cr with double-in-2-years target; Baramati ring mill Q4 startup

  • Capex ambition ₹1,800 Cr tied to customer orders; >1.5x asset turnover expected

  • Marine turbine entry unlocks naval supply chain (shafting, propellers, power-gen, flight subsystems)

  • Structural tailwind: manufacturing shift to India, defense/aerospace/semiconductors secular demand

What the bear case counters
  • Profitability collapsed ₹89.9 Cr despite 18.7% revenue growth

  • Cost inflation recovery 'gradual'; full customer price pass-through uncertain

  • ATAGS FOPM approval delayed ('few weeks'); Odisha mega-project 2.5 years post-approval

  • US tariff overhang (50% raw aluminum, 10–15% components) caps aluminum margin recovery to 15–16%

  • Manpower only 70–75% recovered; migrant labor exodus from Iran war and LPG crisis ongoing

  • European segment (CDP) weak 3% margin; ₹330 Cr redundancy payout over 6–12 months ahead

Risks ranked by how much they should concern a holder

Risk assessment for equity holders

Profitability recovery delayed

HIGH

Cost pass-through to customers is gradual. EBITDA % margin recovery lags per-ton margin normalization because both numerator and denominator move. Consolidated margin may stay compressed H2 FY27.

Capex execution and cost overruns

HIGH

₹1,800 Cr capex over 18 months across simultaneous site launches (Baramati ring mill, Odisha mega-site, Andhra Pradesh energetics, new K Drive plant). Any delay or cost inflation derails return assumptions.

ATAGS FOPM and Odisha timeline slippage

MEDIUM

ATAGS approval stuck in supplier testing ('few weeks' procedural delay); Odisha environmental clearances pending 2.5 years post-approval target end-2026. Slippage pushes H2 defense ramp.

US tariff overhang

MEDIUM

50% raw aluminum tariff from Canada (US has no smelters); 10–15% component tariffs. Caps US aluminum margin recovery to 15–16% vs. prior levels. Depends on US policy correction.

Manpower availability constraints

MEDIUM

Labor normalcy only 70–75%; migrant labor exodus from Iran war and LPG crisis may persist. Wage inflation pressure and capacity constraints in a fast-capex environment.

European restructuring cash drain

MEDIUM

₹330 Cr redundancy payments over 6–12 months; CDP closure Q3 2027. Order transitions to India at 'good margins' but execution risk on margin realization.

How the street is positioned

The market's initial reaction was clear: the stock fell 2.01% on day 1 of the result announcement, with 41.7% delivery suggesting meaningful seller interest into the news. The price action held the decline, signaling that the profit collapse was not forgiven by a long-term narrative upgrade.

At ₹2,088, the stock trades 8.9% below its all-time high of ₹2,292 but has recovered 62.6% from its 52-week low of ₹1,284. It sits below its 20-day (₹2,169) and 50-day (₹2,106) moving averages, suggesting near-term momentum remains challenged. The RSI of 42.9 is neutral—not oversold, but not rebounding either. Below its long-term 200-day average (₹1,750) the stock remains in a structural uptrend, but the near-term technicals are cautious.

Institutional flows tell a nuanced story. FII ownership rose 89 basis points to 15.04%, suggesting selective accumulation despite the profitability miss and near-term headwinds. This is the mark of long-term believers buying the dip. Domestic institutions (DII), however, trimmed 42 basis points to 32.34%, likely profit-taking or rebalancing given the narrowed near-term outlook. The promoter stake remained flat at 44.07%, signaling no insider activity around the result.

The street's verdict: optimistic on the long-term (defense order book, aerospace, capex funded) but skeptical on near-term profitability recovery. The price decline held, not because the story broke, but because recovery is gradual and execution risk is real.

The debate

What to watch next

Catalysts and decision points
  • 1 · Q2 cost recovery and margin trajectory

    Does customer price pass-through accelerate (margin-per-ton back to 26% range)? Does consolidated EBITDA % margin improve to 18–19%? Gradual recovery keeps near-term momentum muted; acceleration unlocks a re-rating.

  • 2 · ATAGS FOPM approval and supplier testing timeline

    Management guided 'few weeks' procedural delay. Any slippage beyond that signals execution risk escalation. H2 defense ramp (ATAGS, CQB serial production) depends on this approval.

  • 3 · US press recovery and capacity utilization

    US operations expected to recover Q2 post-maintenance. If margin trajectory (steel 12%, aluminum 15–16%) realizes, it's a ₹5–10 Cr annual EBITDA tailwind. If tariff overhang persists, upside is capped.

  • 4 · Capex progress: Baramati ring mill and site construction

    Baramati ring mill expected Q4 FY27 production start. Any delays or cost overruns signal execution risk. Odisha mega-project environmental approval status (target end-2026) determines ₹2+ crore long-term capex feasibility.

The honest read

Bharat Forge is a high-quality long-term franchise—precision forging for defense, aerospace, and data centre power systems in a structurally favorable (India shift, manufacturing consolidation) environment. The ₹11.2 crore defense order book is real and multi-year. The marine turbine entry is a game-changer for naval supply chain share.

But Q1 profitability collapse—₹89.9 crore loss despite 18.7% revenue growth—is not transitory noise. It's a call to prove execution. Cost recovery is gradual; capex returns are not yet visible; ATAGS and Odisha timelines are uncertain.

For long-term holders: the thesis survives. For momentum traders: wait for Q2 cost recovery confirmation and capex proof. The stock needs both to accelerate from here. Without them, the order story stays intact, but valuations stay capped.

The number to track: organic EBITDA margin. If Q2 consolidates above 18%, cost recovery is accelerating. If it stays 16–17%, recovery is truly gradual, and patience will be tested. Hold, but don't chase. Let management prove the execution.

Informational and educational content only. Not investment advice.